- Home
- KWR vs RXRX Comparison
KWR vs RXRX Comparison
Compare KWR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KWR | RXRX |
|---|---|---|
| Founded | 1918 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 1985 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KWR | RXRX |
|---|---|---|
| Price | $155.57 | $4.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $149.25 | $7.50 |
| AVG Volume (30 Days) | 135.5K | ★ 24.1M |
| Earning Date | 02-23-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,864,242,000.00 | $43,689,000.00 |
| Revenue This Year | $3.44 | $6.74 |
| Revenue Next Year | $4.15 | $34.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.08 | N/A |
| 52 Week Low | $95.91 | $3.79 |
| 52 Week High | $154.08 | $12.36 |
Technical Indicators
Market Signals| Indicator | KWR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.09 | 55.14 |
| Support Level | $136.34 | $4.62 |
| Resistance Level | $145.30 | $4.98 |
| Average True Range (ATR) | 4.27 | 0.21 |
| MACD | 1.27 | 0.06 |
| Stochastic Oscillator | 100.00 | 71.05 |
Price Performance
Historical ComparisonAbout KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.